Explore more publications!

Trump’s government announces eight new arms package for Taiwan

(MENAFN) The Trump administration has approved eight new arms packages for Taiwan totaling more than $11 billion, a decision widely expected to escalate tensions with China. The State Department’s approvals include an over $4 billion sale of 60 M107A7 Self-Propelled Howitzers and related equipment, 82 M142 HIMARS multiple rocket launchers, 420 Army Tactical Missile Systems (ATACMS), more than $1 billion in ALTIUS tube-launched loitering drone munitions, and $353 million in TOW missiles.

Additional sales authorized include over $1 billion for a Tactical Mission Network, which provides communications for military units along with associated software, equipment, and services, more than $375 million in Javelin missiles, $91.4 million in Harpoon missile repair support and related equipment, and $96 million for AH-1W SuperCobra helicopter spare and repair parts.

Each of these transactions was separately announced by the Defense Security Cooperation Agency (DSCA), which oversees major US arms sales. The notifications trigger a 30-day legislative review period during which Congress can attempt to block the sales via a joint resolution, although no such resolution has ever successfully prevented a DSCA-approved arms transaction, according to the Congressional Research Service.

MENAFN18122025000045017281ID1110496085


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions